At the news
? NEUTRALIMPACT 3/10 CLUSTER filed May 11, 2026 at 20:00 ET
Two insiders at MannKind Corp made open-market sales totaling $66K (0.007% of market cap) on May 12, 2026, one week after the company reported Q1 2026 revenue of $90.2M (+15% YoY) and highlighted upcoming PDUFA dates for Afrezza pediatric (May 29) and Furoscix ReadyFlow Autoinjector (July 26). The sales are trivial relative to the $1.0B market cap and are dwarfed by the $215K in tax-withholding share surrenders by the CEO and other executives on May 11, indicating the open-market sales are likely liquidity-driven rather than signaling a bearish view.
- Open-market sales: EVP Thomson sold $10K, Director Binder sold $56K, total $66K, or 0.007% of $1.0B market cap
- Tax-withholding share surrenders on May 11: CEO Castagna ($123K), EVP Thomson ($44K), Director Binder ($20K), CPWO Tross ($28K), total $215K, non-cash events
- Q1 2026 revenue $90.2M (+15% YoY); Afrezza $15.3M (+3%), Furoscix $15.5M (new), royalties $32.7M (+9%)
- Two upcoming PDUFA dates: Afrezza pediatric (May 29, 2026) and Furoscix ReadyFlow Autoinjector (July 26, 2026)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access